Idaho Falls, ID-based radioisotope manufacturer International Isotopes has posted increased revenue for its second quarter of 2025.
For the period (end-June 30), the company reported revenue of $3.6 million, an increase of $486,087 or 15.3% compared with the same period in the prior year. The growth was driven by the sale of products offered by the firm's Nuclear Medicine Standards division, which saw a 99% increase to $2.3 million for the first six months of 2025, up from $1.2 million for the same period in the prior year. Primarily, this was due to the remedying of the global shortage of cobalt-57 isotope, which lasted from January 2024 to late July 2024, the company noted.
The company posted a net loss for the second quarter of $160,785, down 27% from $233,445 in the same period last year.
